Revvity | PKI - Operating Expenses


Revvity reported $604.27M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
Align Technology USD 821.72M 43.15M Sep/2026
Bio Techne USD 243.9M 17.7M Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Celltrion KRW 133.99B 14.77B Jun/2026
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.36B 4M Sep/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Divis Laboratories Ltd INR 22.52B 3.01B Sep/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Illumina USD 525M 374M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.39B 117.6M Sep/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Organigram Holdings CAD 100.45M 30.86M Jun/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Pharma Mar EUR 46.77M 4.24M Sep/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Quest Diagnostics USD 2.62B 34M Sep/2026
Quidel USD 606.8M 39.4M Sep/2026
Repligen USD 185.01M 2.01M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Sartorius EUR 746.5M 1.3M Sep/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Tilray USD 237.52M 17.34M Sep/2025
Waters USD 527M 592M Jun/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.54B 90.74M Sep/2026